Long-term voluntary running improves diet-induced adiposity in young adult mice

Nutrition Research

Volumn 32, Issue 6, 2012, Pages 458-465

  Yan, Lin ^a   DeMars, Lana C ^a   Johnson, LuAnn K ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Adiposity; Angiogenesis; Inflammation; Mice; Running

Indexed keywords

ADIPOCYTOKINE; ANGIOGENIC FACTOR; CITRATE SYNTHASE; CYTOKINE; INSULIN; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR BB; TRIACYLGLYCEROL; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; FOOD COMPOSITION; INFLAMMATION; LEAN BODY WEIGHT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RUNNING; SEDENTARY LIFESTYLE;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; CHEMOKINE CCL2; DIET, HIGH-FAT; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MOTOR ACTIVITY; OBESITY; PROTO-ONCOGENE PROTEINS C-SIS;

MUS;

EID: 84863089859     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.05.006     Document Type: Article

References (49)

1. Serdula M.K., Ivery D., Coates R.J., Freedman D.S., Williamson D.F., Byers T. Do obese children become obese adults? A review of the literature. Prev Med 1993, 22:167-177.
2. National Institutes of Health Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998, 6(Suppl. 2):51S-209S.
3. Ogden C.L., Carroll M.D., Curtin L.R., Lamb M.M., Flegal K.M. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010, 303:242-249.
4. Ogden C.L. M. C. Prevalence of obesity among children and adolescents: United States, trends 1963-1965 through 2007-2008 http://wwwcdcgov/nchs/data/hestat/obesity_child_07_08/obesity_child_07_08pdf.
5. World Health Organization Obesity: preventing and managing the global epidemic. Report of a WHO consultation 2000, Vol. I-XII:1-253. WHO, Geneva.
6. Caspersen C.J., Powell K.E., Christenson G.M. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985, 100:126-131.
7. Petersen A.M., Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154-1162.
8. White F.C., Bloor C.M., McKirnan M.D., Carroll S.M. Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol 1998, 85:1160-1168.
9. Hudlicka O. The response of muscle to enhanced and reduced activity. Baillieres Clin Endocrinol Metab 1990, 4:417-439.
10. Hudlicka O., Brown M., Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992, 72:369-417.
11. Thompson H.J. Pre-clinical investigations of physical activity and cancer: a brief review and analysis. Carcinogenesis 2006, 27:1946-1949.
12. Vieira V.J., Valentine R.J., Wilund K.R., Antao N., Baynard T., Woods J.A. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am J Physiol Endocrinol Metab 2009, 296:E1164-E1171.
13. Vieira V.J., Valentine R.J., Wilund K.R., Woods J.A. Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice. Cytokine 2009, 46:339-345.
14. Bradley R.L., Jeon J.Y., Liu F.F., Maratos-Flier E. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008, 295:E586-E594.
15. Krawczewski Carhuatanta K.A., Demuro G., Tschop M.H., Pfluger P.T., Benoit S.C., Obici S. Voluntary exercise improves high-fat diet-induced leptin resistance independent of adiposity. Endocrinology 2011, 152:2655-2664.
16. Flurkey K., Currer J.M., Harrison D.E. Mouse models in aging research. The mouse in biomedical research 2007, 639-672. Academic Press, Amsterdam. 2nd ed. J.G. Fox, S.W. Barthold, M.T. Davisson (Eds.).
17. Reeves P.G., Nielsen F.H., Fahey G.C.J. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
18. Institute of Laboratory Animal Research Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, DC.
19. Kennedy S.L., Stanley W.C., Panchal A.R., Mazzeo R.S. Alterations in enzymes involved in fat metabolism after acute and chronic altitude exposure. J Appl Physiol 2001, 90:17-22.
20. Lightfoot J.T., Turner M.J., Daves M., Vordermark A., Kleeberger S.R. Genetic influence on daily wheel running activity level. Physiol Genomics 2004, 19:270-276.
21. Williams K.W., Scott M.M., Elmquist J.K. From observation to experimentation: leptin action in the mediobasal hypothalamus. Am J Clin Nutr 2009, 89:985S-990S.
22. Staiger H., Tschritter O., Machann J., Thamer C., Fritsche A., Maerker E., et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003, 11:368-372.
23. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
24. Tajtakova M., Petrasova D., Petrovicova J., Pytliak M., Semanova Z. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. Endocr Regul 2006, 40:15-19.
25. Bullen J.W., Bluher S., Kelesidis T., Mantzoros C.S. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 2007, 292:E1079-E1086.
26. Franckhauser S., Munoz S., Elias I., Ferre T., Bosch F. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity. Diabetes 2006, 55:273-280.
27. Goldberg I.J., Eckel R.H., McPherson R. Triglycerides and heart disease: still a hypothesis?. Arterioscler Thromb Vasc Biol 2011, 31:1716-1725.
28. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314:1-16.
29. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., et al. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 2005, 13:1311-1320.
30. Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005, 90:2282-2289.
31. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 2003, 100:7265-7270.
32. Nicholl S.M., Roztocil E., Davies M.G. Plasminogen activator system and vascular disease. Curr Vasc Pharmacol 2006, 4:101-116.
33. Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997, 46:860-867.
34. Eriksson P., Reynisdottir S., Lonnqvist F., Stemme V., Hamsten A., Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 1998, 41:65-71.
35. Alessi M.C., Bastelica D., Morange P., Berthet B., Leduc I., Verdier M., et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000, 49:1374-1380.
36. Ma L.J., Mao S.L., Taylor K.L., Kanjanabuch T., Guan Y., Zhang Y., et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004, 53:336-346.
37. Schafer K., Fujisawa K., Konstantinides S., Loskutoff D.J. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 2001, 15:1840-1842.
38. Kawano H., Tsuji H., Nishimura H., Kimura S., Yano S., Ukimura N., et al. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Blood 2001, 97:1697-1702.
39. Cullen J.P., Nicholl S.M., Sayeed S., Sitzmann J.V., Okada S.S., Cahill P.A., et al. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration. Thromb Res 2004, 114:57-65.
40. Uchiyama T., Kurabayashi M., Ohyama Y., Utsugi T., Akuzawa N., Sato M., et al. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2000, 20:1155-1161.
41. Hausman G.J., Richardson R.L. Adipose tissue angiogenesis. J Anim Sci 2004, 82:925-934.
42. Fukumura D., Ushiyama A., Duda D.G., Xu L., Tam J., Krishna V., et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 2003, 93:e88-e97.
43. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034.
44. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686.
45. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000, 96:34-40.
46. Niu J., Azfer A., Zhelyabovska O., Fatma S., Kolattukudy P.E. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 2008, 283:14542-14551.
47. Isogai C., Laug W.E., Shimada H., Declerck P.J., Stins M.F., Durden D., et al. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res 2001, 61:5587-5594.
48. Ding Y.H., Luan X.D., Li J., Rafols J.A., Guthinkonda M., Diaz F.G., et al. Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Curr Neurovasc Res 2004, 1:411-420.
49. Yang H.T., Prior B.M., Lloyd P.G., Taylor J.C., Li Z., Laughlin M.H., et al. Training-induced vascular adaptations to ischemic muscle. J Physiol Pharmacol 2008, 59(Suppl. 7):57-70.